Drug-drug interaction trial with sovaprevir [ACH 1625] and ACH 3102 in healthy subjects.
Phase of Trial: Phase I
Latest Information Update: 23 Apr 2013
At a glance
- Drugs Odalasvir (Primary) ; Sovaprevir (Primary)
- Indications Hepatitis C
- Focus Adverse reactions
- 23 Apr 2013 Results reported at International Liver Congress 2013 at the 48th Annual Meeting of the European Association for the Study of the Liver (EASL), according to an Achillion media release.
- 12 Nov 2012 Results reported in an Achillion Pharmaceuticals media release.
- 12 Nov 2012 Status changed from planning to completed, based on an Achillion Pharmaceuticals media release.